Welcome to the
Hepatitis B Foundation
Biochemist's Find is New Hope for Hep B Cure
July 21 – Dr. Adam Zlotnick at Indiana University has discovered a class of antiviral small molecules that target the viral DNA hidden in the infected livers of hepatitis B patients and could lead to a cure. Novel compounds based on these discoveries, known as Core Protein Allosteric Modulators, or CpAMs, are capable of altering the activities of a core hepatitis B protein that is essential for the virus’s continued survival. Read more.
New York City's Top Hospitals Fail to Vaccinate Newborns Against Hep B, Study Shows
July 21 – All babies should receive the hepatitis B vaccination as soon as they’re born, federal officials say, but advocates say some of the city’s top hospitals are not following recommendations, putting the babies at risk for infection. Two of the hospitals with the lowest vaccination rates in the city are Mount Sinai and Beth Israel, where fewer than 20 percent of babies received the HBV vaccine in 2012, according to Health Department data. And at Maimonides, Tisch and Roosevelt hospitals, just 20 to 40% of newborns got the vaccine that same year. Read more.
HBV Rebounds After Stopping Entecavir, Switching to Interferon May Help
July 21 – Most hepatitis B "e" antigen (HBeAg) negative chronic hepatitis B patients relapsed after stopping treatment with the antiviral drug entecavir (Baraclude), according to a report Gut. A related study found that switching from entecavir to pegylated interferon increased the likelihood of HBeAg seroconversion and hepatitis B surface antigen (HBsAg) loss in HBeAg positive patients. Read more.
July 28 is World Hepatitis Day
1 in 12 people worldwide suffers from chronic hepatitis B and C. World Hepatitis Day aims to increase the awareness and understanding of viral hepatitis as a major global health threat. This year’s theme is “Hepatitis: Think Again.” Join the World Hepatitis Day Thunderclap to be one of thousands of voices sharing the same message on the same day via Facebook and Twitter! Download free campaign materials and read more at www.worldhepatitisalliance.org.
Hep B United Awards $60,000 to Community-Based Organizations
Through a CDC cooperative agreement, the Hepatitis B Foundation is able to provide mini-grants to Hep B United coalition members to address the strategic priorities of improving screening and linkage to care efforts, which have been clearly outlined in the HHS Viral Hepatitis Action Plan. Hep B United is a national coalition established by the Hepatitis B Foundation and Association of Asian Pacific Community Health Organizations to support local hepatitis B coalitions across the country working to eliminate hepatitis B. Learn more.
Visit LiverCancerConnect.org for Valuable Information!
This website is a dedicated program of the Hepatitis B Foundation and is the only patient-focused website available. Learn more about primary liver cancer and visit the physician director, drug watch, clinical trials and listing of listing of cancer centers across the U.S. Visit http://livercancerconnect.org.
Page last modified July 21, 2014